Tag: Loyal Valley Capital
Regor Therapeutics raises $90m for CARD platform in Series B funding round
Regor Therapeutics has raised $90 million in a Series B financing round towards the discovery and development of discovery of drugs for cancer, immune disorders, and metabolic ... Read More
Chinese biopharma company Akeso raises $150m for antibody drug discovery
Akeso, a Chinese biopharma company engaged in antibody drug discovery and development in oncology and immunology therapeutic areas, has raised nearly $150 million through a ... Read More